Navigation Links
Neogen launches rapid tests for ractopamine
Date:3/21/2013

LANSING, Mich., March 21, 2013 /PRNewswire/ -- As international debate continues on the use of the feed additive ractopamine, Neogen Corporation (NASDAQ: NEOG) has launched easy 10 minute tests to detect ractopamine in animal and animal feed samples.

Ractopamine is a beta-agonist drug added to feed to promote lean muscle in animals raised for meat. While many countries allow the use of ractopamine within specified limits, including the United States, regulatory agencies in other countries have banned residues of the drug, including those in the European Union, Russia, and China.

"China recently followed Russia by imposing import restrictions on certain U.S. meat products, which require documentation that the products are free of ractopamine," said Ed Bradley , Neogen's vice president of Food Safety. "While top trade officials in the U.S. view the new restrictions as unnecessary trade barriers, markets in which ractopamine residues are banned are worth hundreds of millions of dollars annually to U.S. meat producers. Until these trade issues can be resolved, companies seeking access to these markets may have no choice but to comply with the new regulations." 

To ensure compliance with the new regulations, animal samples can be easily screened for the presence of ractopamine. In addition, feed manufacturers can use simple screening tests to verify the effectiveness of their cleanup procedures when switching production from ractopamine-medicated feed to feed intended to be ractopamine-free.  

Neogen's Ractopamine Lateral Flow Device (LFD) tests are intended to screen cattle and swine samples, and swine and turkey feed samples for the presence of ractopamine. The tests are one-step screening tests that easily detect the presence of ractopamine at set levels. The ractopamine screening test for swine screens at 2.5 parts per billion (ppb); the test for cattle screens at 1 ppb; and the test for swine and turkey feed screens at 0.5 or 4 parts per million.

The U.S. has set a maximum residue limit for ractopamine at 30 ppb for beef and 50 ppb for pork. The Codex Alimentarius, which creates international food guidelines, has a limit of 10 ppb for pork and beef.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT: Bill Hoerner
Neogen Corporation, 517/372-9200

 


'/>"/>
SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Corporation Announces 3rd Quarter Results Conference Call
2. Neogen reports 30% increase in quarterly net income
3. Neogen Corporation Announces 1st Quarter Results Conference Call
4. Neogen reports year end results
5. Neogen Corporation Announces Year-End Results Conference Call
6. Neogen acquires Igenity from Merial
7. Neogen launches the fastest molecular pathogen test
8. Neogen Launches Fully Quantitative Lateral Flow Test for DON
9. Neogen Reports Second Quarter Results
10. Neogen Corporation Announces 2nd Quarter Results Conference Call
11. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... Feb. 10, 2016  IsoRay, Inc. (NYSE MKT: ISR), ... and medical radioisotope applications for the treatment of prostate, ... announced its financial results for the second quarter and ... 2015. --> --> ... of fiscal 2016, which ended December 31, 2015, a ...
(Date:2/10/2016)... Texas (PRWEB) , ... February 10, 2016 , ... ... centers across three states, announced today the promotion of two long-standing principal investigators ... Chief of Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... their comprehensive training and support program, Sonalinkā„¢ remote monitoring. The inaugural launch of ... on Friday, February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert ...
Breaking Biology Technology:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/18/2016)... Jan. 18, 2016  Extenua Inc., a pioneering ... the use and access of ubiquitous on-premise and ... with American Cyber.  ... leading transformational C4ISR and Cyber initiatives in support ... latest proven technology solutions," said Steve Visconti ...
Breaking Biology News(10 mins):